The nation of Zimbabwe has turned down a significant American health deal worth $367m (272 million pounds) spanning five years because of Washington's demand for sensitive information.
This rejection came to light after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesperson has since clarified that the United States was seeking health data for research and commercial gain but was unwilling to share the benefits from any future vaccines.
"We must now begin the challenging and unfortunate process of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more talks to find a deal suitable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Context
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
After returning to office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
According to statements, Sixteen nations in Africa have to date agreed to these new health pacts, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to share its biological resources and data for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the end products would be accessible to our people if a new health crisis arise."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting frameworks already set up through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage future global health emergencies.
"This framework is designed to guarantee that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," he added.
"We welcome continued discussions with our American counterparts on how future collaboration might be designed in a manner that honours the sovereignty and interests of both nations."
Health Experts Reaction
Medical experts expressed it understood the official position, but suggested that negotiations should continue since a large portion of the country's HIV programmes relied on foreign aid.
"If specific concerns exist, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," it said.
The situation highlights the continuing challenges between accepting much-needed foreign assistance and safeguarding national sovereignty in an ever more interconnected world.